T lymphocytes are important key players that help mediate host protection from viruses by directly killing infected cells and eliminating the pathogen. However, in the setting of chronic viral infections and cancers the virus is never eliminated, and anti-viral T cells differentiate into a state of exhaustion. Exhausted T cells are characterized by their poor effector function, defective proliferation, and inability to kill infected cells. Importantly, high expression of immune checkpoints such as PD-1 during persistent antigen support T cell exhaustion by diminishing T cell receptor signaling. Adhesion molecule, P-selectin glycoprotein ligand-1 (PSGL-1) has recently been identified as a novel immune checkpoint. While studies have shown an improved immune response and elimination of viral particles and tumors with PSGL-1 deficiency or blockade in various disease models, the cell-intrinsic role of PSGL-1 in exhausted T cells remains unknown. In this dissertation, we used an adoptive co-transfer approach utilizing PSGL-1 deficient (Selplg-/-) TCR transgenic (Tg) virus specific T cells in a Lymphocytic choriomeningitis Virus (LCMV) Cl13 mouse model to investigate the function of PSGL-1 in its differentiation, maintenance, and reinvigoration of exhausted T cells. We found that Selplg-/- T cells initially expand to high frequencies in early stages of chronic viral infection, but eventually decrease to very low frequencies as infection progresses. Additionally, we found that while Selplg-/- T cells were initially more functional early during viral infection, they became phenotypically and functionally exhausted as the chronic infection progressed, albeit to a lesser extent than WT. Furthermore, we observed a decrease in progenitor exhausted T cells (Tpex) differentiation and an increase in Tex differentiation in Selplg-/- T cells at late stages of infection. Importantly, we show that Selplg-/- T cells became reinvigorated more effectively than WT after anti-PD-L1 antibody treatment. While we observed improved T cell response with PSGL-1 deficiency in T cells and PD-L1 blockade, the cell intrinsic role of both PSGL-1 and PD-1 combined within T cells has not been explored. In this dissertation, we also used an adoptive co-transfer approach utilizing PSGL-1 and PD-1 deficient (Selplg-/-Pdcd1-/-) TCR transgenic (Tg) virus specific T cells in a Lymphocytic choriomeningitis (LCMV) Cl13 mouse model to investigate any additive effect or synergistic effect that PSGL-1 might have in combination with PD-1, and its impact of differentiation, function, maintenance, and reinvigoration of exhausted T cells. We found that unlike Selplg-/- T cells, Selplg-/-Pdcd1-/- T cells are increased and remain increased throughout the course of chronic viral infection. Interestingly, while Selplg-/- T cells have increased functionality, Selplg-/-Pdcd1-/- T cells are less functional and less cytotoxic at both early and lates stages of infection. Furthermore, we saw that Selplg-/-Pdcd1-/- T cells had decreased and increased levels of TCF1 and TOX, respectively. Consistent with these results, we also observed that the differentiation of Tpex and Tex was more pronounced, with Tpex being further reduced and Tex being further increased in Selplg-/-Pdcd1-/- T cells compared to Selplg-/- T cells. T cells are also important during acute viral infections. They initially expand to kill virally infected cells and then contract and differentiate into different memory T cells as the pathogen is eliminated. Within the memory T cell population, there are subsets of memory T cells, each vital for its various functions. Memory T cells are crucial in that they are quick to respond to a pathogen upon secondary exposure. Prion proteins are glycoproteins expressed on all hematopoietic stem cells, and predominantly known for its role in transmissible spongiform encephalopathies (TSEs). While constitutively expressed on T cells, Prion proteins become highly upregulated after T cell activation. However, the role of Prion protein (Prnp) on effector and memory T cells during viral infection remains unknown. In this dissertation, we utilized acute Lymphocytic choriomeningitis Virus Armstrong (LCMV Arm) on mice deficient in Prnp to investigate the function of Prnp in virus specific T cell and its role in effector T cells and memory T cell differentiation. We found that Prnp deletion increased antigen specific memory T cells, with no differences in effector T cell frequencies. Correspondent with the increase in memory T cells, we also observed increased T cell function at the memory stage in Prnp deficient mice. Importantly, we show that Prnp deficiency changed the memory T cell subset differentiation of effector memory T cells and terminal effector memory T cells (Ttem). Lastly, we assessed the function of memory CD4 T cells and observed an increase in cytokine production in T cells deficient in Prnp. Altogether, this dissertation further contributes a better understanding of how combining multiple immune checkpoints, such as PSGL-1 and PD-1 or targeting novel molecules such as Prion protein impacts the function, differentiation and maintenance on effector, memory, and exhausted T cells. It also provides insight on the mechanisms by which these inhibitory pathways impact T cells and their potential therapeutic value in the settings of viral infections and cancer.